tiprankstipranks
Elevation Oncology (ELEV)
NASDAQ:ELEV
US Market

Elevation Oncology (ELEV) Financial Statements

151 Followers

Elevation Oncology Financial Overview

Elevation Oncology's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Elevation Oncology is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -224.00K$ -10.63M$ -10.11M$ -17.05M$ -20.52M
EBITDA$ -697.00K$ -10.82M$ -10.12M$ -17.20M$ -20.68M
Net Income Common Stockholders$ -7.90M$ -10.64M$ -10.11M$ -17.06M$ -19.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 83.11M$ 94.80M$ 107.92M$ 73.93M$ 90.28M
Total Assets$ 89.09M$ 99.97M$ 110.37M$ 76.90M$ 94.16M
Total Debt$ 30.14M$ 29.95M$ 29.77M$ 29.60M$ 29.43M
Net Debt$ -52.97M$ -64.84M$ -78.15M$ -44.33M$ -60.84M
Total Liabilities$ 34.28M$ 37.56M$ 38.19M$ 43.13M$ 45.13M
Stockholders Equity$ 54.81M$ 62.42M$ 72.17M$ 33.79M$ 49.03M
Cash Flow-
Free Cash Flow$ -12.18M$ -13.36M$ -13.81M$ -16.83M$ -17.85M
Operating Cash Flow$ -12.18M$ -13.36M$ -13.81M$ -16.83M$ -17.85M
Investing Cash Flow$ 6.56M$ -38.12M$ 16.50M$ 26.60M$ 11.18M
Financing Cash Flow$ -2.00K$ 27.00K$ 47.73M$ 216.00K$ -4.00K
Currency in USD

Elevation Oncology Earnings and Revenue History

Elevation Oncology Debt to Assets

Elevation Oncology Cash Flow

Elevation Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis